Soleus Capital Management, L.P. Harpoon Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $544,915 - $757,700	-42,472 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.01 - $18.52 $127,561 - $214,572	11,586 Added 37.51%	42,472 $722,000
Q2 2020 Aug 14, 2020	SELL	$11.11 - $24.72 $4.89 Million - $10.9 Million	-440,040 Reduced 93.44%	30,886 $512,000
Q1 2020 May 15, 2020	BUY	$10.74 - $16.32 $3.73 Million - $5.67 Million	347,726 Added 282.25%	470,926 $5.45 Million
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $1.59 Million - $2.54 Million	123,200 New	123,200 $1.82 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.